We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Novel Culture Medium Developed for Pathogenic Free-Living Amoeba

By LabMedica International staff writers
Posted on 19 Aug 2015
Balamuthia mandrillaris is an opportunistic protist pathogen and the causative agent of necrotizing hemorrhagic granulomatous encephalitis among other infections, with an estimated fatality rate approaching 98%.

B. More...
mandrillaris, unlike most of other free-living amoebae, does not feed on Gram-negative bacteria and therefore the use of non-nutrient agar coated with bacterial cultures has resulted to be ineffective for its growth. Other special medium have been recommended, but they have some disadvantages, as they require many components and their preparations are laborious.

Microbiologists at the Sonora Technological Institute (Mexico) developed an easy-to-prepare culture medium for axenic growth of B. mandrillaris using Cerva's medium as basal component. Ten strains of B. mandrillaris including a well-characterized US Centers for Disease and Prevention (CDC; Atlanta, GA, USA) reference stain and nine environmental isolates from water and soil were used during the study.

Each one of the 11 components of BM-3 culture medium was combined with Cerva's medium as basal culture medium. The cultures were observed daily for a four-week period under an inverted microscope Axiovert 135 (Zeiss; Gottingen, Germany). The number of trophozoites/mL was determined using a hemocytometer, and the doubling time was calculated by linear regression. The yields in each culture were determined at the end of the logarithmic growth phase.

After the first week of daily observations of the tested combinations of BM-3 components and Cerva's medium, amoebae numbers diminished in every flask. At the end of the second week of incubation, neither trophozoites nor cysts were seen in any modification, except for the one consisting of the basal medium complemented with 10× Hank's balanced salt solution (34.0 mL/500 mL) where growth was recovered. Hank's balanced salt solution was the only one that supported confluent growth of B. mandrillaris and where cell shape and motility of trophozoites were normal.

The authors concluded that nutrimental necessity of B. mandrillaris depends on adequate salt solution, protein extracts, and other nutrients obtained from the fetal bovine serum. When using axenic cultures, the development of a cheaper and easy-to-prepare medium for B. mandrillaris opens the possibility of increasing our knowledge on this lethal pathogen. (The study was published in the August 2015 issue of the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Sonora Technological Institute 
Zeiss 



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.